TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Portnoy Law Firm Announces Class Action on Behalf of aTyr Pharma, Inc. Investors

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Lesley F. Portnoy
Portnoy Law Firm Announces Class Action on Behalf of aTyr Pharma, Inc. Investors

The Portnoy Law Firm is advising aTyr Pharma investors about a potential class action lawsuit related to securities purchased between January 16 and September 12, 2025, following a failed Phase 3 clinical trial for efzofitimod.

Insights
ATYR   negative

Stock price fell sharply after announcing that their Phase 3 clinical trial for efzofitimod failed to meet its primary endpoint, indicating significant negative business impact